Corporate | 12 August 2003 07:44

Eckert & Ziegler AG english

Eckert & Ziegler: Increase of Result before Tax Corporate-news announcement sent by DGAP. The sender is solely responsible for the contents of this announcement. ——————————————————————————– Eckert & Ziegler: Increase of Result before Tax Berlin, 12.08.2003. Eckert & Ziegler AG (ISIN DE 0005659700), a specialist in medical and industrial isotope applications, was able to increase its result before tax to 224 TEUR in the first half year of 2003 (2002: -597 TEUR) despite the weak dollar. Total turnover dropped to approximately 13 million EUR (nominally, off by almost 20%; adjusted to account for dollar fluctuations in the market, however, the drop was really about 10%). Cash and marketable securities in contrast increased significantly from 5.5 Mio. EUR to 8.1 Mio EUR, despite a reduction of debt and expenses for a share buy back program. “The revenue decline is mainly attributable to the sale of a business segment and the expected drop in the sales of cardiology products”, explained CEO Dr. Andreas Eckert. “In the other areas we saw stable or increasing turnover. We expect this trend to continue, the more since we recently had a number of successful product introductions in the oncology and the nuclear imaging segment.” For further information please contact: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Strasse 10, D – 13125 Berlin, http://www.ezag.com Tel.: +49 (0) 30 / 94 10 84-138 end of message, (c)DGAP 12.08.2003 ——————————————————————————– WKN: 565970; ISIN: DE0005659700; Index: Listed: Geregelter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, Hannover und Stuttgart 120744 Aug 03